Previous 10 | Next 10 |
Are These Cheap Penny Stocks On Your List Right Now? Penny stocks are well-known for their volatility. Few other asset classes swing hundreds of percentage points in a single session like these cheap stocks. Furthermore, certain sectors have compounded this volatility due to their o...
A tell is a precursor of a stock's next move, and investors in Rockwell Medical (NASDAQ: RMTI) look for these indicators all the time. the good news is, tells are there for investors to see every day. For example, we have provided this data for RMTI in the trading plans and s...
WIXOM, Mich., March 04, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that members of its exec...
Traditionally Wall Street has used fundamental analysis to make investment decisions in stocks like Rockwell Medical (NASDAQ: RMTI) but sometimes the most revealing aspect of the fundamental health of a company can be found through an observation of its price action. Price action ...
Often, the action in a stock is based on investors perceptions, but it can be a circular event. Not only is the price action representative of perception, but it can influence perception too. In the case of Rockwell Medical (NASDAQ: RMTI) we can see this in the charts. ...
WIXOM, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that Triferic AVNU (ferri...
WIXOM, Mich., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management, today announced that its partner in South Korea, Jeil Pharmaceutical Co., Ltd....
Rockwell Medical's (RMTI) partner in China, Wanbang Biopharmaceuticals, has dosed the first patient in Phase 3 trial evaluating Triferic Dialysate for the replacement of iron and maintenance of hemoglobin in hemodialysis patientsThe Phase 3 trial will evaluate the efficacy and safety of Trife...
WIXOM, Mich., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving outcomes for patients around the world, today announced that its ...
Rockwell's sales are expected to increase significantly in 2021 although the firm is still not profitable. The company recently raised more cash to continue its plan to drive value creation. The firm has a big opportunity with its FPC platform and also in international markets. ...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...